Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for elective major orthopedic surgery

Transfusion Alternatives in Transfusion Medicine

Volumn 10, Issue 4, 2008, Pages 166-173

  Bisbe, Elvira ^a   Castillo, Jorge ^a   Sáez, Montserrat ^b   Santiveri, Xavier ^a   Ruíz, Aina ^c   Muñoz, Manuel ^d  

^a HOSPITAL DE L ESPERANÇA   (Spain)

^b HOSPITAL DOS DE MAIG   (Spain)

^c Hospital of Blanes   (Spain)

^d UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Anemia of chronic disease; Folic acid; Iron deficiency; Orthopedic surgery; Prevalence of anemia; Vitamin B 12

Indexed keywords

HEMOGLOBIN;

AGED; ANEMIA; ARTICLE; BLOOD DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DEMOGRAPHY; ELECTIVE SURGERY; FEMALE; FOLIC ACID DEFICIENCY; HEMATINIC DEFICIENCY; HIP ARTHROPLASTY; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; SPINE FUSION;

EID: 64249156561     PISSN: 12959022     EISSN: 1778428X     Source Type: Journal    
DOI: 10.1111/j.1778-428X.2008.00118.x     Document Type: Article

References (36)

1. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: Blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-69.
2. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: A systematic review of the literature. Am J Med 2004; 16 (Suppl. 7A): 58S-69S.
3. Leal SR, Muñoz M, Páramo JA, García-Erce JA, for the Spanish Expert Panel on Alternatives to Allogeneic Blood Transfusion. Spanish consensus statement on alternatives to allogeneic blood transfusions: The Seville document. TATM 2006; 8: 178-202.
4. Beris P, Muñoz M, García-Erce JA, et al. Perioperative anaemia management in surgery: Consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
5. Salido JA, Marin CA, Gómez LA, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: Analysis of predictive factors. J Bone Joint Surg Am 2002; 84: 216-20.
6. García-Erce JA, Solano VM, Cuenca J, Ortega P. La hemoglobina preoperatoria como único factor predictor de las necesidades transfusionales en la artroplastia de rodilla. Rev Esp Anestesiol Reanim 2002; 49: 254-60.
7. Gaskell H, Derry S, Andrew Moore R, McQuay HJ. Prevalence of anaemia in older persons: Systematic review. BMC Geriatr 2008; 8: 1.
8. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated?. J Am Geriatr Soc 2002; 50: 1257-64.
9. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-8.
10. Penninx BW, Guralnik JM, Onder G, et al. Anemia and decline in physical performance among older persons. Am J Med 2003; 115: 104-10.
11. Kikuchi M, Inagaki T, Shinagawa N. Five-year survival of older people with anemia: Variation with hemoglobin concentration. J Am Geriatr Soc 2001; 49: 1226-8.
12. Dunne JR, Malone D, Tracy K, Gannon C, Napolitano LM. Perioperative anemia: An independent risk factor for infection, mortality, and resource utilization in surgery. J Surg. Research 2002; 102: 237-44.
13. Carson JL, Terrin ML, Jay M. Anemia and postoperative rehabilitation. Can J Anaesth 2003; 50 (6 Suppl.): S60-4.
14. García-Erce JA, Cuenca J, Martínez F, et al. Perioperative intravenous iron preserves iron stores and may hasten the recovery from postoperative anaemia after knee replacement surgery. Transfus Med 2006; 16: 335-41.
15. Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology (Am Soc Hematol Educ Program) 2003; 40-61.
16. Carson JL, Poses RM, Spence RK, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet 1988; 1: 727-9.
17. Semba RD, Guralnik JM, Chaves P, Ricks MO, Fried LP. Iron status and anemia in a population-based study of women with and without disability living in the community: The Women's Health and Aging Studies. Haematologica 2004; 89: 357-8.
18. Bisbe E, Rodríguez C, Ruiz A, et al. Uso preoperatorio e hierro endovenoso.Una nueva terapéutica en medicina transfusional. Rev Esp Anestesiol Reanim 2005; 52: 536-40.
19. Andrews CM, Lane DW, Bradley JG. Iron pre-load for major joint replacement. Transfus Med 1997; 7: 281-6.
20. Cuenca J, García-Erce JA, Martínez F, et al. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg 2007; 5: 89-94.
21. Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr 2001; 131: 616S-635S.
22. Harju E. Empty iron stores as a significant risk factor in abdominal surgery. J Parenter Enteral Nutr 1988; 12: 282-5.
23. Clarke R, Refsum H, Birks J, et al. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr 2003; 77: 1241-7.
24. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr 1999; 19: 357-77.
25. Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology (Am Soc Hematol Educ Program) 2003; 62-81.
26. Bisbe E, Sáez M, Pérez C, Castillo J, García-Erce JA. Retraso en la mejoría de la anemia en paciente de artroplastia de cadera tratado con hierro endovenoso y epoetina alfa. Rev Esp Anestesiol Reanim 2005; 52: 507-9.
27. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-8.
28. Muñoz M, Breymann C, García-Erce JA, etal. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008; 94: 172-83.
29. Nilsson-Ehle H, Jagenburg R, Landahl S, Svanborg A, Westin J. Haematological abnormalities and reference intervals in the elderly. A cross-sectional comparative study of three urban Swedish population samples aged 70, 75 and 81 years. Acta Med Scand 1988; 224: 595-604.
30. Couvret C. Recombinant human erythropoietin and management of anemia in orthopedic surgery. TATM 2006; 8: 52-7.
31. Muñoz M, García-Erce JA, Cuenca J, etal. Is there a role for perioperative intravenous iron therapy in orthopedic and trauma surgery? Clinical experience in major lower limb surgery. TATM 2006; 8: 58-67.
32. Bisbe E, Sáez M, Nomen N, et al. Eritropoyetina sola o como coadyuvante del programa de donación de sangre autóloga en cirugía ortopédica mayor. Rev Esp Anestesiol Reanim 2003; 50: 395-400.
33. Bisbe E, Castillo J, Nomen N, et al. Eritropoyetina preoperatoria como estrategia de ahorro de sangre en cirugía ortopédica mayor en pacientes de edad avanzada. Med Clin (Barc) 2004; 123: 413-5.
34. Goodnough LT. Evaluation of anemia in the elective surgical patient. TATM 2007; 9 (Suppl. 2): 10-12.
35. García-Erce JA, Muñoz M, Bisbe E, et al. Predeposit autologous donation in spinal surgery: A multicentre study. Eur Spine J 2004; 13 (Suppl. 1): S34-9.
36. Muñoz M, Kühlmorgen B, Ariza D, et al. Which patients are more likely to benefit from postoperative shed blood salvage after unilateral total knee replacement? An analysis of 581 consecutive procedures. Vox Sang 2007; 92: 136-41.